Announced
Completed
Synopsis
Ardian-backed Biofarma Group, a manufacturer of food supplements, medical devices, probiotic-based drugs and cosmetics, completed the acquisition of US Pharma Lab, a pharmaceutical company. Financial terms were not disclosed. “We are delighted to partner with Amol and the US Pharma Lab team. The combination of Biofarma Group and US Pharma Lab will create the only global CDMO fully focused on Nutraceuticals which will be able to offer significant additional benefits to new and existing customers through a broad range of nutraceutical technologies and R&D capabilities, in addition to providing a harmonized service globally," Gianfranco Nazzi, Biofarma Group CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.